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      The incidence of obesity as a risk factor for normal life is increasing worldwide. Its impact on 
hypertension, cardiovascular diseases, osteoporosis, insulin resistance and diabetes mellitus, is well 
recognized.  Previous studies have proved the association between female obesity and infertility and several 
linked genes have been worked out. However, a little is known about the effect of obesity on male 
reproductive system and infertility. Recently some clinical studies have reported diminished semen 
parameters like sperm count, sperm motility and vitality and changing in reproductive hormones in over 
weight and obese men. Lack of such study in Asian countries and particularly in Indian population who are 
genetically more prone to obesity necessitates picking up this research to achieve robust findings in this 
regard.  
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INTRODUCTION 
The obese male is generally characterized as 
having greater than 25% body fat of total body 
mass with a BMI in excess of 30 kg/m2 [1]. BMI 
is used as the chief indicator of obesity, with 
stratified BMI categories as follows: 18.5–24.9 
kg/m2 (normal), 25 kg/m2 and above 
(overweight) and 30 kg/m2 and above (obese). 
Other more accurate methods to assess obesity 
include measurement of skin fold thickness [2], 
hydrostatic weighing, dual-energy x-ray 
absorptiometry or whole-body adipose tissue 
computed tomography (CT) and MRI combined 
with waist:hip ratio measurements [3]. 
 The potential effects of increased BMI in men 
on fertility have not been subject to the same 
degree of scrutiny as female obesity [4]. Obesity 
in women is known to contribute to anovulation, a 
reduced conception rate and an increased risk of 
miscarriage and prenatal complication [5]. Over 
the years, a number of population-based studies 
have highlighted a trend towards deterioration in 
semen quality [5], showing that overweight and 
obese men have an up to 50% higher rate of sub-
fertility when compared with normal weight men 
[4,6]. Hypotheses put forward to explain this 
decline include increased use of pesticides [7]
,
 
environmental pollutants [8,9], lifestyle factors 
[10], and increasing male obesity.[11]. Table1 
shows the Criteria for a normal semen analysis 
[12]. Apart from these  some more tests done in 
specialized laboratory are Super oxide dismutase 
(SOD), lipid peroxidase, Sperm nuclear chromatin 
decondensation (NCD),  Reactive oxygen Species 
(ROS),and sperm function tests like Hypo 
osmotic swelling test (HOS), estimation of 
seminal fructose and zinc, Immunobed tests etc 
(Table2). In this review article, we aim to focus 
on the association between obesity and male 
fertility, and discuss present treatment or 
management options for this common problem. 




Link between male obesity and fertility 
challenges based of evidences 
Obesity and semen parameters 
Obesity has been shown to be linked to 
reduced spermatogenesis. In a study of 1,558 
military conscripts the total sperm count per 
ejaculate was reduced by 24% in men with a BMI 
> 25 kg/m
2
. The percentage of normal sperm 
morphology was also shown to be adversely 
effected by either high or low BMIs in this study. 
Further, an associated decrease in testosterone, 
follicle stimulating hormone, Inhibin B and sex 
hormone binding globulin was observed in the 
overweight group [11]. A retrospective analysis of 
data from 390 men suggested that high BMI was 
associated with reduced sperm concentration and 
motility [13]. A recent World Health Organization 
surveillance study confirmed that obese men had 
significantly lower total sperm count than non-
obese men, although other sperm parameters were 
not shown to be affected [14]. However, this effect 
on sperm count may be marginal, with analysis of a 
database of 2,139 men finding only a slightly lower 
total sperm count among overweight men and non-
significant change in obese men [15]. A further 
study among men attending an infertility clinic 
showed that despite major changes in reproductive 
hormones, total sperm counts were lower only in 
cases of extreme obesity [16]. 
 A study of 520 Danish men showed a 
significantly reduced number of normal motile 
sperms (normal BMI 18.6 x 10
6
, overweight 3.6 x 
10
6
, obese 0.7 x 10
6
) and importantly an increase in 
sperm DNA fragmentation in overweight and 
obese men [17]. DNA fragmentation index (DFI) is 
the percent of sperm in the semen sample that have 
increased levels of single or double strand breaks 
in nuclear DNA.  Kort et al (2006) showed an 
increase in the DFI in men with high BMI, 
suggesting that obesity might compromise the 
integrity of sperm chromatin. The reference value 
for a young and healthy man is about 3-5% of 
sperm with fragmented DNA while this level is of 
25-30% DFI in a man with high risk for infertility 
[18]. An increase in BMI above 25 kg/m
2 
causes an 
increase in sperm DFI and a decrease in the 
number of normal chromatin-intact sperm per 
ejaculate, relative to the degree of obesity [17]. 
 In another retrospective study of 526 infertile men 
in which the incidence of oligozoospermia and low 
progressive motile sperm concentration was higher 
in overweight and obese men than in normal 
weight men [12]. However, it is important to note 
that many obese men have been shown to have 
normal semen quality and fertility, suggesting that 
the effect of obesity may not be consistent, as 
suggested in a study by Pauli et al (2008)
 
in which 
there was no association between obesity and 
semen quality [2]. However, a recent study by 
Najafi et al (2011) showed a decrease in fertility 
parameters like sperm count and motility among 
overweight and obese men [19]. 
Reproductive hormones imbalance in adult 
obese men  
The endocrine abnormalities associated with 
obesity in women are well known with an increase 
in androgen metabolism and elevated oestrogen 
levels [20]. Obese males usually express a 
characteristic hormonal profile described as 
“hyperestrogenic hypogonadotropic 
hypogonadism.” Total body fat, intra abdominal 
fat, and subcutaneous fat have all been associated 
with low levels of total and free testosterone with a 
decreased ratio of testosterone to estrogen in obese 
men which is due to over activity of the aromatase 
cytochrom P450 enzyme (a product of CYP10 
gene) which is highly expressed in white adipose 
tissue [21, 22]. The aromatization of C19 
androgens such as testosterone and 
androstenedione is a key step in the biosynthesis of 
estrogens [23]. Central obesity in particular appears 
to be associated with a decrease in circulating 




In a recent observational study, despite 
demonstrating relative hypogonadotropic 
hypoandrogenism in obese men, semen analysis 
parameters were unaffected [2] while others have 
shown obesity to be associated with a decrease in 
testosterone and total sperm count [11]. These 
opposing results, suggest that any effect of reduced 
testosterone on male infertility may be modest and 
that further studies are required to give definitive 
answers. Conversely, it has been suggested that 
rather than obesity causing impaired testicular 
function, defective spermatogenesis causes obesity 




[14], with some supporting evidence, such as body 
fat increasing in men receiving therapy to reduce 
testosterone during treatment for prostatic cancer 
[25]. Insulin resistance also is the other suggested 
mechanism to be associated with obesity and is a 
cause of hypoandrogenism and negatively 
correlated with testosterone levels [21].
 












Age-adjusted fasting insulin and C-peptide 
were shown to be inversely correlated to total 
and free testosterone in men [21]. Sex hormone–
binding globulin levels are reduced in obese 
men, an alteration principally mediated by the 
increased circulating insulin levels associated 
with the insulin resistance of obesity [26]. 
 Another suggested cause of endocrine 
changes which is more common in obese 
individuals relates to sleep apnea. Since patients 
with sleep apnea often have fragmented sleep 
course owing to repeated episodes of airway 
obstructions and hypoxia, appears to decrease 
the nocturnal rise of testosterone, resulting in 
lower mean levels of testosterone and LH. 
Luboshitzky et al (2005) showed that sleep 
apnea in obese cases is associated with 
decreased pituitary-gonadal function, and that 
decreased testosterone concentration is due to 
obesity [27]. 
Inhibin B is the most accurate marker for 
regular spermatogenesis in all males [28]. 
Inhibin B marks normal Sertoli cell function and 
associated spermatogenic activity. So it can be 
used to predict the quality of sperm and fertility 
of obese men [29, 30]. It is reported that obese 
men have significantly (25-32%) lower levels of 
Inhibin B than normal levels in non obese men 
[30],  indicates that the production of male 
gametes is seriously impaired in obese males 
[28]. 
 
Obesity and erectile dysfunction  
Another mechanism which has been reported 
in several studies to be more common among in 
men with increased BMI is erectile dysfunction 
[31, 32]. The relationship between erectile 
dysfunction and high BMI can be partly due to 
increased level of several proinfalamtory 
cytokines in obese persons. These inflammatory 
markers are positively associated with impaired 
endothelial function which is directly related to 
male erectile dysfunction. About 76% of men 
who report erectile dysfunction and decrease in 
libido are overweight and obese [2]. 
However, surprisingly when men with reduced 
coital frequency are excluded from the analysis, 
still it has been shown that overweight and 
obese men have increased incidence of sub-
fertility [33]. 
Obesity and increased scrotal temperature  
A high BMI has been postulated to increase in 
scrotal temperature and impair or arrest 
spermatogenesis. Many studies have focused on 
testicular heat stress as a potential risk factor of 
impaired sperm parameters. A study by Hjollund 
et al (2000) shown that even a moderate increase 
in scrotal temperature can be associated with 
substantially reduced sperm concentrations [34]. 
In addition, Magnusdottir et al (2005) concluded 
that increased duration of sedentary posture 
correlated positively with increased scrotal 
Criteria                                 Parameters 
Semen volume                          ≥2 ml 
Semen PH           ≥ 7.2 
Sperm concentration               ≥ 20 × 10
6
 per ml 
Motility                                     > 50% with forward progression 
Total sperm count                   > 40 × 106 sperm 
Morphology                             > 15% normal 
Vitality                                     50% or more live, i.e., excluding dye 
White blood cells        ˂1×10
6 
per ml 




temperature and ultimately a decrease in sperm quality [35]. 
 
Table 2. WHO references for optional tests of semen analysis 
Test                                                 Reference value 
Hypo-osmotic swelling (HOS) test                        ≥ 60% of the spermatozoa undergo tail swelling 
Papanicolaou staining                     ≥15% normal 
Measurement of zinc in seminal plasma                       2.4 µmol or more per ejaculate 
Measurement of fructose in seminal plasma                             13 µmol or more per ejaculate 
Measurement of neutral α-glucosidase in                                  20 mU per ejaculate (minimum) 
seminal plasma    
 
Treatment and management of obesity -
induced infertility in men 
Unlike in women, limited clinical data are 
available on treatment of infertility in obese men. 
However, if the changes that cause infertility by 
obesity are reversible, then change in life style 
and weight loss can be first step and is likely to be 
an effective treatment. Unfortunately, increasingly 
individuals fail to recognize that they are obese, 
and this is more so in men. A recent British 
survey by Johnson et al (2008) showed that 53% 
of the population was overweight or obese, yet in 
obese men only 67% recognized themselves to be 
overweight or obese[36]. Therefore, it is 
important that BMIs are measured in all men 
attending for advice on infertility. Overweight and 
obese men should be informed regarding the 
association between increased weight and 
infertility and strongly advised to aim for a BMI 
of below 25 kg/m2 before starting fertility 
treatment. However, it should be remembered that 
lean muscular men may have high BMIs and 
therefore infertility is not consequent to excess 
adiposity. 
Obesity-induced hypogonadism in males may be 
treated by weight loss, which should reduce 
estrogen levels to normal and alleviate the HPT 
(hypothalamic-pituitary-testicular) feedback 
inhibition [1]. Roux-en-Y gastric bypass surgery, 
one option for the treatment of morbid obesity, 
has been shown in one study to seemingly reverse 
abnormal reproductive hormonal profiles, such 
that total testosterone is increased and serum 
estradiol is decreased [37]. Other treatment 
options for hypogonadism include 
supplementation with alternative or recombinant 
gonadotropins (e.g., human chorionic 
gonadotropin [hCG] and recombinant FSH), 
which stimulate testicular function, including 
testosterone production [38]. Finally, aromatase 
inhibitors, letrozole and anastrozole, can be used 
to prevent enzymatic conversion of androgens to 
estrogens in adipocytes and other tissues [23,38], 
thereby reducing serum estradiol and suppression 
of the HPT axis by interrupting the hypogonadal–
obesity cycle [39]. Much more researches are 
required to evaluate the effect of these treatments 
on improvement of fertility in obese men.  
 
CONCLUSION  
There are an ever-growing number of reports 
concerning increasing number of overweight and 
obese men in the developed countries. The 
changes in sperm parameters and reproductive 
hormones (including testosterone, estrogen and 
Inhibin B) in obese men reported in recent studies 
emphasize on a link between obesity and 
spermatogenesis and erectile dysfunction. Though 
there is some inconsistency in the results of 
previous studies to measure semen parameters 
affected by obesity, the consistent increase in 
leptin levels and decrease in Inhibin B levels seen 
in all obese – infertile cases indicate a fault in 
normal spermatogenesis and sperm quality. We 
hope this review will be a call to launch genetic 
and molecular studies to unveil the molecular 
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